ACTR-13. FINAL RESULTS WITH CHEMORADIOTHERAPY FOR ANAPLASTIC OLIGODENDROGLIAL TUMORS FROM NRG ONCOLOGY/RTOG 9402

BACKGROUND: Adding intensive-procarbazine, lomustine, and vincristine (iPCV) to radiotherapy (RT) prolonged progression-free (PFS) and overall survival (OS) for patients with 1p19q codeleted anaplastic oligodendroglial tumors (AOTs); some benefit was also observed for IDH-mutant non-codeleted cases...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Neuro Oncol
Hlavní autoři: Lassman, Andrew, Won, Minhee, Gregory Cairncross, J, Shaw, Edward, Ashby, Lynn, Souhami, Luis, Laack, Nadia, Fink, Karen, Macdonald, David, Bahary, Jean-Paul, Hartford, Alan, Whitton, Anthony, Werner-Wasik, Maria, Laperriere, Normand, Suh, John, Robinson, Clifford, Mehta, Minesh
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2019
Témata:
Adult Clinical Trials - Non-Immunologic
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847175/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.056
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky